Ziqin Wang | Toxicology and Pharmaceutical Science | Innovative Research Award

Published on by Invention Awards

Innovative Research Award

Ziqin Wang
Beijing Chaoyang Kaiwen Academy

Researcher Profile
Affiliation Beijing Chaoyang Kaiwen Academy
Country China
Subject Area Toxicology and Pharmaceutical Science
Event International Invention Awards
ORCID 0009-0004-2036-3316

Ziqin Wang is associated with Beijing Chaoyang Kaiwen Academy in China, with toxicology and pharmaceutical science identified as the relevant subject areas in the supplied profile. These disciplines investigate the biological effects of chemical substances, pharmaceutical safety, therapeutic development, and evidence-based approaches to evaluating medicines.methodological quality, and research relevance. Specific publications, research achievements, and bibliometric indicators require independent verification before attribution. Established toxicological assessment principles and pharmaceutical research guidance provide a foundation for evaluating scientific contributions in these fields.[1][2]

Abstract

This article presents an academic recognition profile for Ziqin Wang of Beijing Chaoyang Kaiwen Academy, China, in connection with the Innovative Research Award and the International Invention Awards. The stated subject areas are toxicology and pharmaceutical science, which encompass chemical safety, biological responses, therapeutic substances, and pharmaceutical development. The profile outlines relevant research themes and describes considerations for evaluating originality, methodological quality, scientific integrity, and practical relevance. Specific publications, research achievements, citation counts, and other bibliometric indicators have not been independently verified. Authoritative institutional records and scholarly databases should be consulted before attributing individual accomplishments or drawing conclusions about research impact or award eligibility.

Keywords

Ziqin Wang, Innovative Research Award, International Invention Awards, toxicology, pharmaceutical science, drug safety, pharmacological research, chemical risk assessment, pharmaceutical innovation, scientific research, biomedical development, research evaluation.

Introduction

Scientific innovation advances knowledge by introducing new methods, testing hypotheses, and addressing unresolved research questions. Toxicology and pharmaceutical science contribute to this process through investigations of chemical hazards, biological mechanisms, drug safety, and therapeutic development. Evaluating work in these areas requires attention to experimental design, reproducibility, ethical conduct, and the strength of supporting evidence. Internationally recognized scientific and pharmaceutical guidance provides useful context for understanding these requirements.[1][2]

Research Profile

The supplied information identifies Ziqin Wang with Beijing Chaoyang Kaiwen Academy in China and lists toxicology and pharmaceutical science as relevant subject areas. These fields combine concepts from chemistry, biology, pharmacology, and health sciences to examine the effects of substances and the development of therapeutic products. The available information does not independently establish a specific research appointment, degree, laboratory affiliation, or publication history. Additional details should be confirmed through institutional documentation, scholarly records, or the researcher’s verified public profile before inclusion in a formal academic biography.[3]

Research Contributions

Potential contributions within toxicology and pharmaceutical science include the assessment of chemical hazards, analysis of dose-response relationships, investigation of biological mechanisms, and development of improved methods for evaluating substance safety. Pharmaceutical research can also address formulation, drug delivery, analytical techniques, and the evaluation of therapeutic candidates. These examples describe the broader scientific disciplines and should not be interpreted as confirmed achievements by Ziqin Wang. Individual discoveries, inventions, experimental results, or original methods should be attributed only when supported by identifiable publications, patents, institutional records, or other reliable evidence.[1][2]

Publications

A verified publication record helps establish research activity, subject expertise, and scholarly contributions. Relevant materials may include peer-reviewed journal articles, conference papers, research reports, and publications describing original experimental findings. Each record should be checked for authorship, publication details, journal information, and a persistent identifier such as a digital object identifier (DOI), when available. No specific publication or DOI has been verified for this profile. Consequently, publication titles and numerical research indicators should be added only after checking appropriate scholarly databases and original publication records.[3]

Research Impact

Research impact can be examined through scientific quality, reproducibility, independent citation, practical application, and relevance to important research questions. In toxicology and pharmaceutical science, meaningful outcomes may include stronger safety assessment methods, improved understanding of biological effects, or evidence that supports further therapeutic development. Citation counts and h-index values can indicate aspects of scholarly visibility but cannot independently establish originality or practical benefit. An evidence-based assessment of Ziqin Wang’s research impact requires verified publications, documented research outputs, and independent evidence of how the work has contributed to scientific understanding or subsequent applications.[1]

Award Suitability

The Innovative Research Award provides a framework for recognizing work that may demonstrate originality, methodological rigor, scientific relevance, and responsible innovation. In toxicology and pharmaceutical science, a nomination may be supported by documented research findings, validated methods, relevant publications, patents, or evidence of practical application. The supplied profile information alone is insufficient to establish award eligibility or determine the strength of a nomination. A fair assessment should use the International Invention Awards’ applicable eligibility requirements and evaluation criteria, supported by reliable documentation and a transparent review process.[3]

Conclusion

This profile presents Ziqin Wang in the context of Beijing Chaoyang Kaiwen Academy, China, and the subject areas of toxicology and pharmaceutical science. It outlines the broader scientific context of the Innovative Research Award and the importance of originality, reproducibility, and evidence-based evaluation. A complete academic assessment requires verified scholarly outputs, documented research achievements, and confirmation of the relevant award criteria. The inclusion of numbered references links the discussion to sources on toxicological assessment, pharmaceutical guidance, and researcher identification, while maintaining a clear distinction between supplied profile information and independently established facts.

References

  1. ORCID. (n.d.). ORCID: Connecting Research and Researchers. ORCID.
    https://orcid.org/0009-0004-2036-3316
  2. Journal article. (2026. ) Cardiolipin-Specific Targeting of Melittin via Arg22 in Lipid Membranes: A Natural Toxin-Based Strategy for Treating Mitochondrial Dysfunction in Aging and Disease.
    https://doi.org/10.3390/toxins18100432
  3. International Invention Awards. (2026.). Official website.
    https://inventionawards.org/

Rupa Mazumder | Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by Invention Awards

Best Researcher Award

Rupa Mazumder
Noida Institute of Engineering And Technology

Rupa Mazumder
Affiliation Noida Institute of Engineering And Technology
Country India
Scopus ID 7005832705
Documents 211
Citations 1,412
h-index 18
Subject Area Toxicology and Pharmaceutical Science
Event International Invention Awards
ORCID 0000-0002-1888-548X

Rupa Mazumder is a researcher affiliated with the Noida Institute of Engineering And Technology, India, whose documented scholarly profile is associated with toxicology and pharmaceutical science. The supplied Scopus record reports 211 documents, 1,412 citations, and an h-index of 18, providing a bibliometric basis for considering the researcher within an academic recognition framework. [1]

Abstract

Rupa Mazumder is an India-based researcher affiliated with the Noida Institute of Engineering And Technology and associated with the subject area of Toxicology and Pharmaceutical Science. The supplied bibliometric profile records 211 scholarly documents, 1,412 citations, and an h-index of 18. These indicators provide measurable evidence of sustained research activity and scholarly visibility. Her profile is considered in relation to the Best Researcher Award under the International Invention Awards framework. Assessment of researcher recognition may consider publication productivity, citation influence, research continuity, subject expertise, and the broader relevance of scientific contributions. Bibliometric information should be interpreted alongside verified qualitative evidence and individual research outputs for balanced academic evaluation.

Keywords

Rupa Mazumder; Best Researcher Award; Toxicology; Pharmaceutical Science; Drug Research; Pharmacology; Research Impact; Scholarly Publications; Citation Analysis; h-index; Scientific Research; International Invention Awards.

Introduction

Researcher recognition in pharmaceutical and toxicological sciences commonly involves consideration of scholarly productivity, research quality, citation performance, and sustained engagement with scientific questions. Bibliometric indicators can provide a structured quantitative perspective, although they do not independently establish the originality or practical significance of individual studies. The available profile for Rupa Mazumder presents a substantial publication and citation record that can be examined as part of a broader academic assessment. [1] Standardized researcher identifiers such as Scopus Author ID and ORCID can also assist in distinguishing scholarly outputs and improving the reliability of attribution. [2]

Research Profile

The supplied profile identifies Rupa Mazumder with the Noida Institute of Engineering And Technology in India and places the research activity within Toxicology and Pharmaceutical Science. The reported Scopus Author ID is 7005832705, while the associated ORCID is 0000-0002-1888-548X. These persistent identifiers provide complementary mechanisms for connecting scholarly records with an individual researcher and can support verification across academic databases. [1] [2]

Research Contributions

Within toxicology and pharmaceutical science, research contributions may encompass the investigation of drug effects, safety, pharmacological mechanisms, toxicological responses, therapeutic development, and related biomedical questions. The available information does not provide a complete thematic inventory of Rupa Mazumder’s individual studies, so specific scientific claims should be based on verified publication records rather than inferred solely from bibliometric indicators. The documented publication volume nevertheless indicates sustained participation in scholarly research. [1]

Publications

The supplied Scopus information records 211 documents associated with the researcher profile. Publication counts are useful for describing research productivity but should be evaluated with attention to document type, authorship, journal quality, research field, chronology, and subject relevance. A complete publication assessment would require examination of the underlying indexed records and individual bibliographic metadata. The reported document count is therefore presented as a profile-level bibliometric indicator rather than as an independent measure of research quality. [1]

Research Impact

The supplied profile reports 1,412 citations and an h-index of 18. Citation indicators can help describe the visibility and scholarly uptake of published research, while the h-index combines productivity and citation dimensions into a single metric. Such measures vary across disciplines, career stages, database coverage, and publication practices and should therefore be interpreted within appropriate academic context. [1] Citation-based assessment is strongest when complemented by qualitative evidence concerning originality, methodological contribution, collaboration, and influence on subsequent research.

Award Suitability

The available bibliometric information provides a relevant quantitative foundation for consideration for the Best Researcher Award. The combination of 211 reported documents, 1,412 citations, and an h-index of 18 indicates an established scholarly record within the supplied profile. [1] Final award suitability should, however, be determined through verification of the researcher identity, publication record, research quality, originality, professional contributions, and alignment with the applicable award criteria. The profile therefore supports consideration without implying that bibliometric measures alone determine award outcome.

Conclusion

Rupa Mazumder’s supplied academic profile documents substantial scholarly activity in the field of Toxicology and Pharmaceutical Science, with 211 documents, 1,412 citations, and an h-index of 18. These indicators establish a useful quantitative basis for academic recognition while requiring contextual interpretation. [1] Verification through persistent researcher identifiers, indexed publications, and qualitative evidence can strengthen the assessment. On the information provided, the profile presents a credible basis for consideration under the Best Researcher Award category of the International Invention Awards.

References

  1. Elsevier. (n.d.). Scopus author details: Rupa Mazumder, Author ID 7005832705. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7005832705
  2. ORCID. (n.d.). ORCID record: Rupa Mazumder, ORCID 0000-0002-1888-548X. ORCID.
    https://orcid.org/0000-0002-1888-548X
  3. Journal article. (2026).Preparations, Applications, Patents, and Marketed Formulations of Nanoemulsions – A Comprehensive Review.
    http://dx.doi.org/10.2174/0122117385325186240912110731
  4. Journal article. (2025). A Comprehensive Investigation on the Role of Bioactives on DYRK1A to Avert Alzheimer’s Disease.
    https://doi.org/10.18311/jnr/2025/49903
  5. International Invention Awards. (2026. ). Official award website.
    https://inventionawards.org/

Shiva Vairale | CSIR – National Chemical Laboratory | Best Researcher Award

Published on by Invention Awards

Best Researcher Award

Shiva Vairale
CSIR – National chemical Laboratory

Shiva Vairale
Affiliation CSIR – National Chemical Laboratory
Country India
Scopus ID 60050407800
Documents 6
Citations 9
h-index 3
Subject Area Drug Discovery
Event International Invention Awards
Google Scholar Rgn4SCoAAAAJ

Shiva Vairale is a researcher affiliated with the CSIR – National Chemical Laboratory in India, with research interests associated with biochemical sciences and drug discovery. Publicly indexed research records connect his work with bioactive molecules, natural products, biological macromolecules, antimicrobial investigations, and pharmacological applications. His research activities include collaborative studies addressing biologically relevant compounds and their potential therapeutic significance. Available publication records identify contributions to peer-reviewed research involving sericin-based nanotherapeutics and insect-derived metabolites, illustrating an interdisciplinary orientation spanning biochemistry, pharmacology, and translational drug-discovery research. [1]

Abstract

Shiva Vairale is a researcher at CSIR – National Chemical Laboratory whose documented work focuses on biochemical sciences, natural bioactive compounds, and drug discovery. His research profile includes investigations of biologically active molecules, therapeutic mechanisms, antimicrobial activity, and emerging nanotherapeutic approaches. Published work has addressed sericin-based formulations for anti-urolithiatic and antibacterial applications, while a recent review examines insect-derived metabolites and their pharmacological potential in modern drug discovery. These studies reflect an interdisciplinary research direction connecting biochemistry, natural products, pharmacology, molecular mechanisms, and translational applications. His indexed research record provides measurable indicators of scholarly activity and citation-based visibility.

Keywords

Shiva Vairale, Best Researcher Award, drug discovery, biochemical sciences, natural products, insect-derived metabolites, pharmacology, bioactive compounds, sericin nanotherapeutics, antimicrobial research, therapeutic applications, CSIR-National Chemical Laboratory, India.

Introduction

Drug discovery increasingly integrates natural-product chemistry, molecular biology, pharmacology, and advanced formulation strategies to identify biologically useful compounds. Within this multidisciplinary landscape, Vairale’s documented research is associated with the investigation of bioactive substances and their therapeutic relevance. His work at CSIR-National Chemical Laboratory places these activities within an established Indian research environment focused on chemical and biological sciences. [2] Recent publications further demonstrate engagement with natural metabolites and biological macromolecules as potential sources of pharmacological applications. [3]

Research Profile

Vairale’s research profile is situated primarily within biochemical sciences and drug discovery. Publicly available institutional and bibliographic information associates him with the Biochemical Sciences Division of CSIR-National Chemical Laboratory and with research involving bioactive compounds, biological assays, natural metabolites, and therapeutic applications. His academic record also places his doctoral research within biological sciences, supporting an interdisciplinary trajectory connecting chemical and biological investigation. [2]

Research Contributions

A documented contribution involves research on sericin-based nanotherapeutics, examining sericin and related nanoparticle formulations for anti-urolithiatic and antibacterial applications. The study combines biological macromolecules, nanotechnology, characterization, and pharmacological assessment. [1] Another contribution is a review of insect-derived metabolites in drug discovery, covering chemically diverse metabolites and their biological mechanisms while considering their translational relevance to pharmacotherapy. [4]

Publications

Vairale has contributed to peer-reviewed publications spanning natural products, biological macromolecules, antimicrobial research, and drug discovery. A notable publication is Sericin-based nanotherapeutics: A dual-action biological macromolecule for anti-urolithiatic and antibacterial applications, published in the International Journal of Biological Macromolecules in 2025 with DOI 10.1016/j.ijbiomac.2025.146763. [1] His 2026 review, Insect derived metabolites in drug discovery: Pharmacological potential, mechanisms, and translational challenges, appeared in Pharmacological Research – Natural Products, DOI 10.1016/j.prenap.2026.100808. [4]

Research Impact

The research addresses scientific questions relevant to therapeutic discovery, particularly the identification and characterization of biologically active substances. Work on sericin-based systems explores potential applications against urolithiasis and bacterial activity, while research concerning insect metabolites considers their broader pharmacological potential. These themes are relevant to continuing efforts to identify new biological resources and mechanisms for therapeutic development. The supplied bibliometric profile records six documents, nine citations, and an h-index of three. [1]

Award Suitability

For recognition under a Best Researcher Award category, the documented record provides evidence of peer-reviewed research activity, interdisciplinary subject engagement, and identifiable contributions to drug-discovery research. Relevant evidence includes publications involving biological macromolecules and natural metabolites, collaboration across research groups, and indexed bibliometric indicators supplied for this profile. The award record should be considered alongside the complete nomination materials and applicable evaluation criteria of the International Invention Awards. [5]

Conclusion

Shiva Vairale’s documented research activity reflects an interdisciplinary focus on biochemical sciences and drug discovery, with published work addressing sericin-based nanotherapeutics and insect-derived metabolites. His research connects natural bioactive resources with pharmacological investigation and potential therapeutic applications. The available bibliometric information and publication record provide a structured basis for describing his scholarly profile and its relevance to research recognition within the International Invention Awards.

References

  1. Elsevier. (n.d.). Scopus Author Details: Author ID 60050407800. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=60050407800
  2. Review article. (2026). Insect derived metabolites in drug discovery: Pharmacological potential, mechanisms, and translational challenges.
    https://doi.org/10.1016/j.prenap.2026.100808
  3. Research article. (2025). Sericin-based nanotherapeutics: A dual-action biological macromolecule for anti-urolithiatic and antibacterial applications.
    https://doi.org/10.1016/j.ijbiomac.2025.146763
  4. Google Scholar. (n.d.). Google Scholar author profile: Shiva Vairale. Google Scholar.
    https://scholar.google.com/citations?hl=en&user=Rgn4SCoAAAAJ
  5. International Invention Awards. (2026). International Invention Award.
    https://inventionawards.org/

Stephen Chelko | Toxicology and Pharmaceutical Science | Innovative Research Award

Published on by Invention Awards

Innovative Research Award

Stephen Chelko
Florida State University College of Medicine

Stephen Chelko
Affiliation Florida State University College of Medicine
Country United States
Scopus ID 54973874200
Documents 47
Citations 1,649
h-index 18
Subject Area Toxicology and Pharmaceutical Science
Event International Invention Awards
ORCID 0000-0003-1675-5945

Stephen Chelko is a researcher affiliated with the Florida State University College of Medicine whose documented scholarly profile is associated with toxicology and pharmaceutical science. Available bibliometric information records 47 documents, 1,649 citations, and an h-index of 18, providing a quantitative basis for assessing research visibility and scholarly influence. [1]

Abstract

Stephen Chelko is a researcher associated with Florida State University College of Medicine and the fields of toxicology and pharmaceutical science. His indexed scholarly record comprises 47 documents, 1,649 citations, and an h-index of 18, according to the supplied Scopus profile information. These indicators provide a measurable basis for describing his research visibility and citation impact within scholarly databases. His profile may be considered in the context of recognition for innovative research, particularly where scientific investigation, translational relevance, and contribution to biomedical knowledge are central criteria. The Innovative Research Award provides a framework for highlighting documented scholarly achievement and research significance.

Keywords

Stephen Chelko; Innovative Research Award; toxicology; pharmaceutical science; biomedical research; Florida State University College of Medicine; research impact; scholarly publications; citation analysis; translational science.

Introduction

Academic recognition commonly considers the quality, relevance, originality, and influence of a researcher’s scholarly work. In this context, Stephen Chelko’s documented profile combines research activity in toxicology and pharmaceutical science with measurable bibliometric indicators. The available Scopus record identifies 47 documents, 1,649 citations, and an h-index of 18. [1]

Research Profile

Chelko’s stated subject area is Toxicology and Pharmaceutical Science, positioning his scholarly profile within disciplines concerned with biological effects, therapeutic development, pharmaceutical research, and related biomedical questions. His affiliation with Florida State University College of Medicine further places this work within an academic medical environment. [4]

Research Contributions

The available information supports describing Chelko’s contribution through his documented publication record and citation footprint rather than assigning unsupported claims about individual discoveries. Forty-seven indexed documents indicate sustained scholarly output, while the recorded citation count suggests that his published research has been referenced by subsequent academic literature. [1]

Publications

The supplied researcher profile reports 47 documents indexed in Scopus. Because complete publication titles, journals, publication years, and article-level DOI information were not supplied, this page does not attribute individual papers or DOI records without verification. The Scopus author profile provides the appropriate source for reviewing the complete indexed publication record. [1]

Research Impact

Research impact can be assessed through several complementary dimensions, including scholarly citations, publication continuity, disciplinary relevance, and potential contribution to scientific practice. Chelko’s reported 1,649 citations and h-index of 18 provide quantitative indicators of scholarly visibility, although bibliometric measures should be interpreted alongside qualitative assessment of research originality and significance. [1]

Award Suitability

The documented research profile is relevant to an Innovative Research Award because it demonstrates sustained scholarly activity in a biomedical subject area and a measurable citation record. Final award suitability should nevertheless depend on the official nomination criteria, verified publications, originality of contributions, supporting evidence, and independent evaluation by the responsible award committee. [5]

Conclusion

Stephen Chelko’s supplied academic profile presents a researcher working in toxicology and pharmaceutical science, affiliated with Florida State University College of Medicine. The reported record of 47 documents, 1,649 citations, and an h-index of 18 provides a measurable foundation for academic recognition. These indicators should be considered together with verified research quality and innovation.

References

  1. Elsevier. (n.d.). Scopus author details: Stephen Chelko, Author ID 54973874200. Scopus.
    https://www.scopus.com/pages/authors/54973874200
  2. ORCID. (n.d.). Stephen Chelko, ORCID iD 0000-0003-1675-5945. ORCID.
    https://orcid.org/0000-0003-1675-5945
  3. Google Scholar. (n.d.). Stephen Chelko — Google Scholar profile.
    https://scholar.google.com/citations?hl=en&user=5Hq6SM0AAAAJ
  4. Journal article. (2019.). Therapeutic Modulation of the Immune Response in Arrhythmogenic Cardiomyopathy.
    https://doi.org/10.1161/CIRCULATIONAHA.119.040676
  5. International Invention Awards. (2026.). Official Award Information.
    https://inventionawards.org/

Avijit Mazumder | Toxicology and Pharmaceutical Science | Best Academic Researcher Award

Published on by Invention Awards
After Completing the Registration Process, your Biography will be displayed here.

Register by using your Entry ID: 26246

Register Here

 

Nusret Erdogan | Toxicology and Pharmaceutical Science | Research Excellence Award

Published on by Invention Awards
After Completing the Registration Process, your Biography will be displayed here.

Register by using your Entry ID: 26022

Register Here

 

Assoc. Prof. Dr. Yousef Bin Jardan | Pharmaceutical Sciences | Best Researcher Award

Published on by Invention Awards

Assoc. Prof. Dr. Yousef Bin Jardan | Pharmaceutical Sciences | Best Researcher Award

King Saud University, Saudi Arabia.

Yousef Abdullah M. Bin Jardan, PhD is an Associate Professor in the Department of Pharmaceutics at King Saud University, Riyadh, Saudi Arabia. He currently serves as the Director of the Experimental Animal Care Centre at the College of Pharmacy. His expertise lies in pharmacokinetics, drug metabolism, and analytical method development. With extensive academic and administrative experience, he actively contributes to teaching, research, and institutional development.

Profile

Scopus
Orcid

🎓 Education

Assoc. Prof. Dr. Yousef Bin Jardan holds a Ph.D. in Pharmaceutical Sciences from the University of Alberta, Canada, which he earned in 2017. He previously obtained his B.Sc. in Pharmaceutical Sciences from King Saud University, Saudi Arabia, in 2009. With a strong academic background and expertise in pharmaceutical sciences, Dr. Bin Jardan has contributed to research and education in the field, focusing on advancements in drug development and healthcare. His work continues to enhance the understanding and application of pharmaceutical sciences in both academic and professional settings.

🎓 Academic Positions

Assoc. Prof. Dr. Yousef Bin Jardan has a distinguished academic career in pharmaceutical sciences, with extensive experience in teaching and research. Since April 2022, he has been serving as an Associate Professor in the Department of Pharmaceutics at King Saud University, contributing to advanced research and mentoring students in pharmaceutical sciences. Prior to this, he worked as an Assistant Professor at the same department from 2017 to 2022, where he played a key role in curriculum development and scientific research.

Before joining King Saud University as a faculty member, Dr. Bin Jardan gained valuable experience as a Graduate Teaching & Research Assistant at the University of Alberta, Canada, from 2010 to 2017. During this period, he was actively involved in laboratory research and student instruction. His academic journey began as a Teaching Assistant at King Saud University in 2009, where he supported undergraduate education and research activities.

👨‍🏫 Teaching Experience

Assoc. Prof. Dr. Yousef Bin Jardan is actively involved in pharmaceutical education, teaching key courses at King Saud University. He instructs Pharmaceutical Calculations (PHT 210 – PharmD), equipping students with essential mathematical skills for accurate drug formulation and dosing. Additionally, he teaches Biopharmaceutics (PHT 414 – B.Pharm & PHT 417 – PharmD), focusing on drug absorption, distribution, metabolism, and elimination, crucial for understanding drug efficacy and safety. He also oversees Internship Training (PHTR 211 – PharmD), guiding students through practical experiences in clinical and pharmaceutical settings. His commitment to teaching ensures that future pharmacists receive both theoretical knowledge and hands-on expertise in the field.

🏢 Administrative Roles

Assoc. Prof. Dr. Yousef Bin Jardan has held several key academic and administrative positions at King Saud University. Since 2019, he has served as the Director of the Experimental Animal Care Centre, overseeing research involving laboratory animals and ensuring ethical standards in scientific studies. Prior to this role, he was the Assistant Vice-Dean for Graduate Studies & Research from 2018 to 2019, where he played a pivotal role in enhancing research initiatives and supporting postgraduate programs. In 2018, he also briefly served as the Assistant Vice-Dean for Development & Quality, focusing on improving academic standards and institutional excellence. His leadership and contributions have significantly advanced pharmaceutical research and education at King Saud University.

🏛️ Council & Committee Memberships

Pharmaceutics Department Council Member – (2017–Present)

Academic Committee Member – College of Pharmacy (2017–2018)

Annual Research Day Committee Member – (2017–2018)

🔬 Research Interests

Analytical method development for drugs and metabolites in biological matrices

Pharmacokinetics, pharmacodynamics, and drug metabolism in laboratory animals and humans

Drug-disease interactions using in vivo models

🏆 Awards & Recognitions

Distinction Award for Academic Excellence – Saudi Arabian Cultural Bureau, Canada (2011, 2013)

Graduate Student Award – University of Alberta (2014)

Graduate Students' Association Academic Travel Award – University of Alberta (2015, 2016)

CSPS Meeting Travel Award – Faculty of Pharmacy, University of Alberta (2015, 2016)

🎓 Licenses & Certifications

Licensed Pharmacist – Saudi Commission for Health Specialties (SCFHS) (2010–Present)

📜 Notable Publications

Herb-drug interaction: Pharmacokinetics and pharmacodynamics of anti-hypertensive drug amlodipine besylate in presence of Lepidium sativum and Curcuma longa
Xenobiotica; the Fate of Foreign Compounds in Biological Systems (2022-02-01)

Contributors: Yousef A Bin Jardan, Alam MA, Bin Jardan YA, Mohammad Raish, Al-Mohizea AM, Ahad A, Al-Jenoobi FI

Deciphering chemical profiling, pharmacological responses, and potential bioactive constituents of Saussurea lappa Decne. extracts through in vitro approaches
Saudi Journal of Biological Sciences (2022-01-24)

Contributors: Yousef A Bin Jardan, Naseer S, Iqbal J, Naseer A, Kanwal S, Hussain I, Tan Y, Aguilar-Marcelino L, Raquel Cossio-Bayugar, Zajac Z et al.

Novel high-throughput green UPLC-MS/MS methods for determination of desmopressin with special sample handling
Journal of the Indian Chemical Society (2021)

Contributors: Alam MA, Al-Jenoobi FI, Bin Jardan YA, Altamimi MA, Alshehri SM

Effects of garden cress, fenugreek, and black seed on the pharmacodynamics of metoprolol: An herb-drug interaction study in rats with hypertension
Pharmaceutical Biology (2021-12-01)

Contributors: Yousef A Bin Jardan, Bin Jardan YA, Ahad A, Mohammad Raish, Alam MA, Al-Mohizea AM, Al-Jenoobi FI

Eudragit-coated sporopollenin exine microcapsules (SEMC) of Phoenix dactylifera L. for 5-Fluorouracil colon-specific drug delivery
Pharmaceutics (2021-11-12)

Contributors: Yousef A Bin Jardan, Mohammad Raish, Dr. Mohd Abul Kalam, Ahmad A, Mudassar Shahid, Mushtaq Ahmad Ansari, Abdul Ahad, Ali R, Bin Jardan YA, Aws Alshamsan et al.

 

 

Dr. Nik Kuznetsov | Aging biology | Best Researcher Award

Published on by Invention Awards

Dr. Nik Kuznetsov | Aging biology | Best Researcher Award

KI, UAEU, Sweden.

Dr. Nik Kuznetsov is a molecular biologist with extensive expertise in genomics, transcriptomics, and molecular diagnostics. With a Ph.D. in Molecular Biology, he has contributed significantly to biomedical research, space medicine, and drug discovery. His work spans gene expression profiling, biomarker discovery, personalized medicine, and microgravity research, with applications in immunology, aging, and neuroscience. Currently, he serves as a Senior Visiting Research Scientist at the United Arab Emirates University, continuing his cutting-edge research in human health and space biology.

Profile

Google Scholar

🎓 Education

Nik Kuznetsov holds a Ph.D. in Molecular Biology, where he specialized in advanced genomic applications and molecular mechanisms in cellular responses. Prior to this, he earned an M.Sc. in Biochemistry, gaining expertise in protein interactions, enzymatic pathways, and molecular signaling. His academic foundation was built with a B.Sc. in Cell Biology, focusing on cellular structures, genetic regulation, and biochemical processes. His multidisciplinary education has enabled him to contribute significantly to research in molecular genetics, bioinformatics, and space biomedicine.

🧪 Professional Experience

A highly experienced molecular biologist, currently serving as a Senior Visiting Research Scientist at United Arab Emirates University, with a strong background in molecular genetics, biotechnology, and drug discovery. Previously, he worked as a Senior Research Specialist & Lab Manager at Karolinska Institute, Sweden (2014–2022), where he managed laboratory operations and contributed to cutting-edge biomedical research. His industry experience includes serving as a Senior Scientist in Drug Discovery & Development at InDex Pharmaceuticals, Sweden (2012–2013) and as a Research Scientist at InDex Pharmaceuticals AB & InDex Diagnostics AB (2002–2011), where he played a crucial role in molecular diagnostics and therapeutic innovations. His academic career began with postdoctoral fellowships at the Karolinska Institute (1999–2001) and the Marie Curie Research Institute, UK (1997–1998), supported by the Royal Society. His expertise encompasses molecular biology, biochemistry, and cell biology, with a strong focus on translational research and pharmaceutical development.

🔬 Research Interests

Genomics & Transcriptomics: RNA-seq, ChIP-seq, RIP-seq, gene expression profiling

Molecular Biology & Bioinformatics: DNA-protein interactions, biomarker discovery

Space Biology & Aging: T-cell response in microgravity, neurodegeneration in astronauts

Personalized Medicine: Drug discovery, nucleic acid-based therapies

Immunology & Inflammation: Role of T-cells in disease and adaptive immune responses

🏆 Awards & Fellowships

2023: Best Presentation Award, UAE Microbiome 2023, Abu Dhabi, UAE

2018 – 2021: Swedish National Space Agency Research Grant, Sweden

2015 – 2020: Travel Grant Awards, Karolinska Institute, Sweden

1997 – 1998: Royal Society Postdoctoral Fellowship, UK

📚 Selected Publications

Kuznetsov NV (2025). Expression of the p53 network aging-associated genes "shaken, not stirred" in a 3-week microgravity simulation human study. bioRxiv.

Kuznetsov NV, et al. (2025). An Update on Neuroaging on Earth and in Spaceflight. IJMS.

Kuznetsov NV, et al. (2025). Hallmarks of Brain Plasticity. Biomedicines.

Kuznetsov NV, et al. (2023). Reappraisal of the concept of accelerated aging in neurodegeneration and beyond. Cells.

Kuznetsov NV, et al. (2023). Exposure of volunteers to microgravity by dry immersion results in gene expression changes and adaptation of T cells. Science Advances.

 

 

Prof. Dr. Antonio Rescifina | Chemistry | Best Researcher Award

Published on by Invention Awards

Prof. Dr. Antonio Rescifina | Chemistry | Best Researcher Award

University of Catania, Italy.

Prof. Dr. Antonio Rescifina, born on December 23, 1964, in Messina, Italy, is a distinguished researcher and professor in Organic Chemistry. He currently serves as a Full Professor in the Department of Pharmaceutical Sciences at the University of Catania, where he has been a member of the faculty since 1996. His research focuses on the synthesis of organic compounds with applications in pharmaceuticals, environmental chemistry, and materials science.

Profile

Scopus

Orcid

Education 🎓

Prof. Rescifina holds a degree in Chemistry and Pharmaceutical Technology from the University of Messina (1989), with honors. He later obtained another degree in Pharmacy (1991) and completed a Ph.D. in Chemical Sciences with a specialization in Organic Chemistry from the University of Catania (1995).

Experience 💼

Prof. Rescifina has had an extensive career in research and teaching. He worked as a researcher at the University of Catania and the University of Messina before becoming a professor. Over the years, he has contributed significantly to scientific advancements in organic chemistry, working on numerous projects funded by both national and international organizations. His roles have included being a scientific coordinator of various research projects.

Research Interests 🔬

Organic Chemistry and Pharmaceutical Applications
Dr. Yucra's work primarily focuses on the synthesis of novel chemical compounds for pharmaceutical and industrial applications. His research aims to create more efficient, cost-effective, and sustainable solutions to current challenges in these sectors.

Carbon Dioxide Decarbonization & Valorization
He is committed to developing innovative carbon dioxide decarbonization and valorization processes, which aim to transform CO₂ from a harmful greenhouse gas into valuable industrial products, contributing to environmental sustainability.

Green Chemistry
Dr. Yucra emphasizes green chemistry principles, working on solutions that minimize environmental impact, enhance energy efficiency, and reduce the use of toxic chemicals, all while maintaining effective chemical processes.

Pharmaceutical Nanostructures
In his work on pharmaceutical nanostructures, he explores the development of nanoscale materials that can be used for targeted drug delivery, improving the effectiveness of treatments while reducing side effects.

Supramolecular Catalysis
His interest in supramolecular catalysis focuses on creating catalysts that work through non-covalent interactions, leading to more efficient and selective chemical reactions, with potential applications in pharmaceuticals and green chemistry.

Sustainable Chemistry Materials
Finally, Dr. Yucra is involved in the design and development of innovative materials for sustainable chemistry, aiming to create alternatives to traditional chemical processes that are more sustainable, eco-friendly, and economically viable.

.

Awards 🏆

Prof. Rescifina's work has earned him national recognition, including the prestigious Abilitazione Scientifica Nazionale (National Scientific Qualification) for Full Professor in 2018.

His research contributions have been acknowledged in various funded projects and prestigious conferences.

Selected Publications 📚

Designing a Monolithic Photo-Fenton Catalyst Using a Fungal Hydroxypyrone Metabolic Derivative
Materials Today Chemistry
March 2025 | Journal article
Contributors: Elisabetta Grazia Tomarchio, Valentina Giglio, Chiara Zagni, Sabrina Carola Carroccio, Vincenzo Paratore, Guglielmo Guido Condorelli, Giuseppe Floresta, Sandro Dattilo, Antonio Rescifina.

Efficient Green Solvent-Free CO2/Epoxide Cycloaddition Catalyzed by a β-Cyclodextrin-Imidazolium-Based Ionic Liquid
Journal of Industrial and Engineering Chemistry
March 2025 | Journal article
Contributors: Elisabetta Grazia Tomarchio, Chiara Zagni, Rita Turnaturi, Sandro Dattilo, Vincenzo Patamia, Giuseppe Floresta, Sabrina Carola Carroccio, Tommaso Mecca, Antonio Rescifina.

A Full Carbon-Based Thermoplastic Photocatalyst for Organic Pollutants Abatement: An Experimental and Computational Study
FlatChem
January 2025 | Journal article
Contributors: Lidia Mezzina, Angelo Nicosia, Vincenzo Patamia, Antonio Rescifina, Luisa D’Urso, Vincenzo Paratore, Placido Giuseppe Mineo.

Enhancing HDAC Inhibitor Screening: Addressing Zinc Parameterization and Ligand Protonation in Docking Studies
International Journal of Molecular Sciences
January 20, 2025 | Journal article
Contributors: Rocco Buccheri, Alessandro Coco, Lorella Pasquinucci, Emanuele Amata, Agostino Marrazzo, Antonio Rescifina.

Bio-Based Palladium Catalyst in Cryogel for Cross-Coupling Reactions
Materials Chemistry Frontiers
2024 | Journal article
Contributors: Elisabetta Grazia Tomarchio, Chiara Zagni, Vincenzo Paratore, Guglielmo Guido Condorelli, Sabrina Carola Carroccio, Antonio Rescifina.

 

 

Xiaochun Li | Biomedical | Best Researcher Award

Published on by Invention Awards

Prof Dr. Xiaochun Li | Biomedical | Best Researcher Award

Associate Dean, Taiyuan University of Technology, China

Dr. Xiaochun Li is a Professor at the Department of Biomedical Engineering, TaiYuan University of Technology, Shanxi, China. With an extensive background in biomedical sensors and analytical chemistry, Dr. Li has made significant contributions to the field through innovative research and teaching. He has received multiple awards for his work, including the Second Prize of the Shanxi Provincial Natural Science Award and recognition as the “2021 Annual Science and Technology Innovation Person.” His research focuses on developing cutting-edge technologies for disease diagnosis and public health.

Profile

Scopus

Education 🎓

Dr. Xiaochun Li earned his Ph.D. in Biomedical Engineering, specializing in analytical chemistry and sensor technology. His educational journey laid a strong foundation for his future research and academic career, leading to his current position as a professor at TaiYuan University of Technology.

Experience 🧑‍🏫

Professor, TaiYuan University of Technology, Shanxi, China (2014-present): Leading research in biomedical sensors and analytical chemistry.

Associate Professor, TaiYuan University of Technology, Shanxi, China (2009-2014): Conducted advanced research and taught various courses.

Assistant Professor, TaiYuan University of Technology, Shanxi, China (2007-2009): Initiated his academic career, focusing on innovative research in biomedical engineering.

Research Interests 🔬

Dr. Xiaochun Li’s research interests encompass the development of biomedical sensors, optical fluorescence detection technologies, and AI-enhanced biochemical sensing. His work is particularly focused on creating innovative diagnostic tools for early disease detection and public health applications.

Awards 🏆

Second Prize of Shanxi Provincial Natural Science Award (2022)

Outstanding Science and Technology Worker of China Society of Electronics (2019)

Silver Prize of National Science and Technology Workers’ Innovation and Entrepreneurship Competition (2016)

Young Outstanding Talents of Shanxi Province “Three Jin Talents” (2018)

2021 Annual Science and Technology Innovation Person (2022)

Publications Top Notes 📚

Zhang, L. L., Xu, P. T., Li, X. C., Yang, Z. H., Yu, H.-Z.. (2024). Blu-ray disc technology-enabled portable imaging system for immunoassay quantitation. Sens. Actuat. B-Chem., 419, 136376. Cited by 15 articles. link

Wang, C. X., Deng, R., Li, H. Q., Liu, Z. G., Niu, X. F., Li, X. C.. (2024). An integrated magnetic separation enzyme-linked colorimetric sensing platform for field detection of Escherichia coli O157: H7 in food. Microchimica Acta, 191, 454. Cited by 10 articles. link

Li, H. Q., Xu, H., Li, Y. L., Li, X. C.*. (2024). Application of artificial intelligence (AI)-enhanced biochemical sensing in molecular diagnosis and imaging analysis: Advancing and challenges. Trac-Trend. Anal. Chem., 174, 117700. Cited by 12 articles. link